Commonwealth Equity Services’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-9,468
Closed -$205K 4092
2024
Q1
$205K Sell
9,468
-1,211
-11% -$30.1K ﹤0.01% 3606
2023
Q4
$309K Sell
10,679
-1,353
-11% -$36.2K ﹤0.01% 3142
2023
Q3
$322K Sell
12,032
-2,427
-17% -$82.9K ﹤0.01% 2969
2023
Q2
$535K Sell
14,459
-529
-4% -$18.4K ﹤0.01% 2551
2023
Q1
$467 Buy
14,988
+353
+2% +$11.4K ﹤0.01% 2619
2022
Q4
$435K Sell
14,635
-762
-5% -$27.3K ﹤0.01% 2582
2022
Q3
$586K Sell
15,397
-438
-3% -$22K ﹤0.01% 2265
2022
Q2
$863K Sell
15,835
-4,384
-22% -$241K ﹤0.01% 2016
2022
Q1
$1.26M Buy
20,219
+646
+3% +$42.5K ﹤0.01% 1817
2021
Q4
$1.97M Buy
19,573
+1,694
+9% +$149K ﹤0.01% 1505
2021
Q3
$1.61M Sell
17,879
-3,812
-18% -$346K ﹤0.01% 1580
2021
Q2
$2M Buy
21,691
+6,074
+39% +$485K 0.01% 1417
2021
Q1
$1.51M Buy
15,617
+8,640
+124% +$892K ﹤0.01% 1509
2020
Q4
$363K Buy
+6,977
New +$292K ﹤0.01% 2406

Other funds holding FLGT

Commonwealth Equity Services's FLGT Position: Q2 2024 in Review

Commonwealth Equity Services sold out of Fulgent Genetics (FLGT) in Q2 2024, closing a stake of 9,468 shares — an estimated $205K sold.

Commonwealth Equity Services first reported a position in FLGT in Q4 2020 and held it in 14 quarters. The position peaked at $2M in Q2 2021. 173 funds tracked by Wall St. Rank hold FLGT as of Q2 2024.

  • Commonwealth Equity Services reported no remaining Fulgent Genetics position as of Q2 2024 after selling out during the quarter.
  • Commonwealth Equity Services sold 9,468 Fulgent Genetics shares in Q2 2024, an estimated $205K.
  • Commonwealth Equity Services first reported a position in Fulgent Genetics in Q4 2020 and held it in 14 quarters.
  • Commonwealth Equity Services's Fulgent Genetics position peaked at $2M in Q2 2021.
  • 173 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2024.

Based on Commonwealth Equity Services's 13F filing for Q2 2024, filed 31 Jul 2024.